These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7617714)

  • 21. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin (5-HT) systems mediate dopamine (DA) receptor supersensitivity.
    Kostrzewa RM; Gong L; Brus R
    Acta Neurobiol Exp (Wars); 1993; 53(1):31-41. PubMed ID: 8317265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitro-l-arginine attenuates SKF 38393-induced oral activity in neonatal 6-hydroxydopamine-lesioned rats.
    Brus R; Szkilnik R; Nowak P; Kostrzewa RM
    Acta Neurobiol Exp (Wars); 1997; 57(4):283-7. PubMed ID: 9519546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disinhibition of nucleus accumbens neurons by the dopamine D2 receptor agonist LY-141865: prevented by 6-OHDA pretreatment.
    Hu XT; Wang RY
    Brain Res; 1988 Mar; 444(2):389-93. PubMed ID: 2965961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM; Marin C; Susel Z; Chase TN
    Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Timing: A critical determinant of the functional consequences of neonatal 6-OHDA lesions.
    Neal-Beliveau BS; Joyce JN
    Neurotoxicol Teratol; 1999; 21(2):129-40. PubMed ID: 10192273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study.
    Hassani OK; Féger J
    Neuroscience; 1999; 92(2):533-43. PubMed ID: 10408602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
    Paul ML; Currie RW; Robertson HA
    Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats.
    Plech A; Brus R; Kalbfleisch JH; Kostrzewa RM
    Psychopharmacology (Berl); 1995 Jun; 119(4):466-73. PubMed ID: 7480527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa.
    Asin KE; Bednarz L; Nikkel A; Perner R
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1483-90. PubMed ID: 7791123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
    Garrett BE; Holtzman SG
    Eur J Pharmacol; 1994 Sep; 262(1-2):65-75. PubMed ID: 7813580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopaminergic neuronal systems modulate the central cardiovascular effects of TRH in rats.
    Jedrusiak J; Brus R; Kostrzewa RM; Słowiński Z
    Pol J Pharmacol; 1995; 47(1):43-52. PubMed ID: 7550548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine and 5-HT receptor sensitivity does not correlate with neostriatal dopamine or 5-HT content.
    Kostrzewa RM; Brus R; Perry KW; Fuller RW
    Acta Neurobiol Exp (Wars); 1996; 56(1):21-8. PubMed ID: 8787176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal 6-hydroxydopamine and adult SKF 38393 treatments alter dopamine D1 receptor mRNA levels: absence of other neurochemical associations with the enhanced behavioral responses of lesioned rats.
    Gong L; Kostrzewa RM; Li C
    J Neurochem; 1994 Oct; 63(4):1282-90. PubMed ID: 7931280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.